Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026

AI Briefing

• – Mdxhealth presents data from Oxford's ProMPT study showing GPS test predicts adverse outcomes in prostate cancer patients
• – The study demonstrates the GPS test's effectiveness across various treatment settings
• – The findings were presented at the European Association of Urology 2026 conference